Thierry Guillaudeux Yumanity Therapeutics, Inc. (YMTX) insider trading activity

YMTX Quotes by TradingView

Thierry Guillaudeux is Chief Scientific Officer of YUMANITY THERAPEUTICS, INC.. Currently has a direct ownership of 0 shares of YMTX, which is worth approximately $0. The most recent transaction as insider was on Jun 30, 2025, when has been sold 217,333 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0
100.0% 3M change
100.0% 12M change
Total Value Held $0

Thierry Guillaudeux Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 30 2025
SELL
Sale (or disposition) back to the issuer
-
217,333 Reduced 100.0%
0 Common Stock
Jun 25 2025
BUY
Grant, award, or other acquisition
-
23,100 Added 9.61%
217,333 Common Stock
Jun 23 2025
SELL
Payment of exercise price or tax liability
$12,388 $0.26 p/Share
47,647 Reduced 19.7%
194,233 Common Stock
Jun 23 2025
BUY
Exercise of conversion of derivative security
$81,000 $0.36 p/Share
225,000 Added 47.7%
246,696 Common Stock
Sep 14 2023
BUY
Open market or private purchase
$20,000 $2.0 p/Share
10,000 Added 31.55%
21,696 Common Stock
Dec 16 2022
BUY
Grant, award, or other acquisition
-
11,696 Added 50.0%
11,696 Common Stock
TG

Thierry Guillaudeux

Chief Scientific Officer
Seattle, WA

Track Institutional and Insider Activities on YMTX

Follow YUMANITY THERAPEUTICS, INC. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells YMTX shares.

Notify only if

Insider Trading

Get notified when an Yumanity Therapeutics, Inc. insider buys or sells YMTX shares.

Notify only if

News

Receive news related to YUMANITY THERAPEUTICS, INC.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on YMTX